In 2013, the journal Science chose cancer immunotherapy as the breakthrough of the year, largely due to the impact of checkpoint inhibitors. Interleukin-2 (IL-2), a cytokine, also played a part. In addition to IL-2, interferon-gamma (IFN-g), and interleukin-12 (IL-12) have come to prominence in recent years. However, toxicity limits their use. Can this be overcome?
The liver is the largest vital organ responsible for functions including metabolism, immunity, digestion, detoxification and endocrine regulation. Its multifaceted role, unique anatomical features and specialized blood supply - receiving blood directly from the GI tract and heart - render it an indispensable target for therapeutic interventions aimed at addressing liver diseases and improving overall health outcomes.
Inflammation is a natural biological response to tissue injury or infection, but chronic low-grade inflammation, also known as inflammaging, is a hallmark of ageing. In recent years, the relationship between cytokines, inflammation, and ageing has become established.
Chocolate directly affects immune system performance. Stripping back the confounding effects of other components, such as sugar, cocoa itself promotes beneficial changes which are reflected in levels of pro- and anti-inflammatory cytokines.
It is said that a drug without side effects is a drug without efficacy. Could the same be true of artificial sweeteners? Are we hoping too much that the sweetness we crave can be satisfied without the normal cost in calories, cavities and surges in blood sugar levels?
If you are an adult, there is a high probability you already have liver disease. Even if you are of average weight and teetotal. Non-alcoholic fatty liver disease (NAFLD) now affects more than 30% of the world's population, a number that has risen rapidly over the last 20 years. Cytokines are key modulators of liver disease and understanding their role may be key to improved therapies.
Purified recombinant proteins are used in products ranging from biological soap powders to cutting-edge medicines. The rate at which these proteins degrade is critical to their function. Technologies that address the rate of degradation and enable novel applications can transform the value of a protein
Cochlear implants (CIs) do not produce the same rich sound experience that can be provided by properly functioning ears. One limitation on performance is the quality of connection CIs form with auditory nerves they electrically stimulate. This connection may be improved by co-implanting iPSC-derived otic neuronal progenitor cells to help bridge the gap. A “neurotrophic strip†containing slowly releasing growth factors that generate a growth factor gradient ensures these neurons extend in the right direction.
A team at UC Davis Medical Centre in Sacramento, California, have used mesenchymal stem cell (MSC) patches to treat spina bifida. Although still experimental, with outcomes yet unknown in the few babies that received the treatment, earlier work on English bulldogs and other models of spinal cord injury suggests this approach may be useful to treat spina bifida.
For a drug to be successful, just as important as what the drug does to the body, is what the body does to the drug. Not only is it important to transport therapeutic drugs effectively to where they are needed, but once it is there, they have to remain long enough to have an effect. Studies to understand a drug's journey through the body are in the domain of drug metabolism and pharmacokinetics, usually abbreviated to DMPK.
